Kidney Disease Clinical Trials in Philadelphia

Showing 61-80 of 393 trials

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

NCT05501054

To learn if the combination of ciforadenant, ipilimumab, and nivolumab can help to control advanced renal cell carcinoma

Renal Cell Carcinoma

M.D. Anderson Cancer Center50 participantsStarted Feb 2023

Durham, North Carolina, United States • Philadelphia, Pennsylvania, United States • Houston, Texas, United States

COMPLETEDNA< 1 mile

Virtual Nephrologist

NCT06841016

To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.

Chronic Kidney Disease(CKD)

University of Pennsylvania148 participantsStarted Mar 2024

Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States

COMPLETEDPhase 3< 1 mile

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

NCT00506441

This is a phase III multi-centre study in three periods: the first period is a phosphate binder washout for 4 weeks, the second period is an open-label, flexible dose titration, the third period is a placebo-controlled withdrawal comparing MCI-196 with placebo for 4 weeks.

Chronic Kidney DiseaseDialysisHyperphosphatemia

Tanabe Pharma Corporation245 participantsStarted Sep 2007

Glendale, Arizona, United States • Tempe, Arizona, United States • Hot Springs, Arkansas, United States +36 more locations

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Virtual Nephrologist

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Kidney Disease Trials in Other Cities

Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

VIRTUUS Children's Study

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Other Conditions in Philadelphia